未登录 Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC 携带EGFR突变型晚期非小细胞肺癌患者使用amivantamab-lazertinib的总体生存率 Yang, James Chih-Hsin; Lu, Shun; Hayashi, Hidetoshi; Felip, Enriqueta; Spira, Alexander I.; Girard, Nicolas; Kim, Yu Jung; Lee, Se-Hoon; Ostapenko, Yurii; Danchaivijitr, Pongwut; Liu, Baogang; Alip, Adlinda; Korbenfeld, Ernesto; Mourao Dias, Josiane; Besse, Benjamin; Passaro, Antonio; Lee, Ki-Hyeong; Xiong, Hailin; How, Soon-Hin; Cheng, Ying; Chang, Gee-Chen; Yoshioka, Hiroshige; Thomas, Michael; Nguyen, Danny; Ou, Sai-Hong Ignatius; Mukhedkar, Sanjay; Prabhash, Kumar; D'Arcangelo, Manolo; Alatorre-Alexander, Jorge; Vazquez Limon, Juan Carlos; Alves, Sara; Stroyakovskiy, Daniil; Peregudova, Marina; Sendur, Mehmet Ali Nahit; Yazici, Ozan; Califano, Raffaele; Gutierrez Calderon, Vanesa; de Marinis, Filippo; Kim, Sang-We; Gadgeel, Shirish M.; Owen, Scott; Xie, John; Sun, Tao; Mehta, Jaydeep; Venkatasubramanian, Raja; Ennis, Mariah; Fennema, Elizabeth; Daksh, Mahesh; Roshak, Amy; Man, Julie; Knoblauch, Roland E.; Bauml, Joshua M.; Baig, Mahadi; Shah, Sujay; Sethi, Seema; Cho, Byoung Chul 分享 收藏
分享 收藏
分享 收藏
Sotorasib versus docetaxel for previously treated KRAS G12C-mutated non-small-cell lung cancer: a plain language summary de Langen, Adrianus Johannes; Johnson, Melissa L.; Mazieres, Julien; Dingemans, Anne-Marie C.; Mountzios, Giannis; Pless, Miklos; Wolf, Juergen; Schuler, Martin; Lena, Herve; Skoulidis, Ferdinandos; Yoneshima, Yasuto; Kim, Sang-We; Linardou, Helena; Novello, Silvia; van der Wekken, Anthonie J.; Chen, Yuanbin; Peters, Solange; Felip, Enriqueta; Solomon, Benjamin J.; Ramalingam, Suresh S.; Dooms, Christophe; Lindsay, Colin R.; Ferreira, Carlos Gil; Blais, Normand; Obiozor, Cynthia C.; Wang, Yang; Mehta, Bhakti; Varrieur, Tracy; Ngarmchamnanrith, Gataree; Stollenwerk, Bjoern; Waterhouse, David; Paz-Ares, Luis 分享 收藏
分享 收藏
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC Amivantamab联合Lazertinib治疗先前未经治疗的EGFR突变的晚期NSCLC Cho, Byoung C.; Lu, Shun; Felip, Enriqueta; Spira, Alexander I.; Girard, Nicolas; Lee, Jong-Seok; Lee, Se-Hoon; Ostapenko, Yurii; Danchaivijitr, Pongwut; Liu, Baogang; Alip, Adlinda; Korbenfeld, Ernesto; Mourao Dias, Josiane; Besse, Benjamin; Lee, Ki-Hyeong; Xiong, Hailin; How, Soon-Hin; Cheng, Ying; Chang, Gee-Chen; Yoshioka, Hiroshige; Yang, James C. -H.; Thomas, Michael; Nguyen, Danny; Ou, Sai-Hong I.; Mukhedkar, Sanjay; Prabhash, Kumar; D'Arcangelo, Manolo; Alatorre-Alexander, Jorge; Vazquez Limon, Juan C.; Alves, Sara; Stroyakovskiy, Daniil; Peregudova, Marina; Sendur, Mehmet A. N.; Yazici, Ozan; Califano, Raffaele; Gutierrez Calderon, Vanesa; de Marinis, Filippo; Passaro, Antonio; Kim, Sang-We; Gadgeel, Shirish M.; Xie, John; Sun, Tao; Martinez, Melissa; Ennis, Mariah; Fennema, Elizabeth; Daksh, Mahesh; Millington, Dawn; Leconte, Isabelle; Iwasawa, Ryota; Lorenzini, Patricia; Baig, Mahadi; Shah, Sujay; Bauml, Joshua M.; Shreeve, S. Martin; Sethi, Seema; Knoblauch, Roland E.; Hayashi, Hidetoshi 分享 收藏
Updated overall survival and ctDNA analysis in patients with EGFR T790M-positive advanced non-small cell lung cancer treated with lazertinib in the phase 1/2 LASER201 study 1/2期LASER201研究中使用拉泽替尼治疗的EGFR T790M-positive晚期非小细胞肺癌患者的更新的总生存期和ctDNA分析 Han, Ji-Youn; Ahn, Myung-Ju; Lee, Ki Hyeong; Lee, Yun-Gyoo; Kim, Dong-Wan; Min, Young Joo; Kim, Sang-We; Cho, Eun Kyung; Kim, Joo-Hang; Lee, Gyeong-Won; Lee, Sung Sook; Lee, Na Mi; Jang, Hyun Woo; Han, Heewon; Park, Hyejoo; Lee, Jieon; Cho, Byoung Chul 分享 收藏
Alectinib Versus Crizotinib in Asian Patients With Treatment-Naïve Advanced ALK-Positive NSCLC : Five-Year Update From the Phase 3 ALESIA Study Zhou, Caicun; Lu, You; Kim, Sang-We; Reungwetwattana, Thanyanan; Zhou, Jianying; Zhang, Yiping; He, Jianxing; Yang, Jin-Ji; Cheng, Ying; Lee, Se-Hoon; Chang, Jianhua; Fang, Jian; Liu, Zhe; Bu, Lilian; Qian, Li; Xu, Tingting; Archer, Venice; Hilton, Magalie; Zhou, Mingzhu; Zhang, Li 分享 收藏
Avelumab in Combination With Lorlatinib or Crizotinib in Patients With Previously Treated Advanced NSCLC: Phase 1b/2 Results From the JAVELIN Lung 101 Trial Solomon, Benjamin J.; Dagogo-Jack, Ibiayi; Lee, Se-Hoon; Boyer, Michael J.; Ramalingam, Suresh S.; Carcereny, Enric; Felip, Enriqueta; Han, Ji-Youn; Hida, Toyoaki; Hughes, Brett G. M.; Kim, Sang -We; Nishio, Makoto; Seto, Takashi; Okamoto, Tatsuro; Zhang, Xiaoxi; Martini, Jean -Francois; Wang, Erjian; De Beukelaer, Steven; Bauer, Todd M. 分享 收藏
A Brief Report of Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: Outcomes by Tumor PD-L1 Expression in the Phase 3 POSEIDON Study Durvalumab加或不加Tremelimumab联合化疗作为转移性非小细胞肺癌一线治疗的简要报告: POSEIDON 3期研究中肿瘤PD-L1表达的结果 Garon, Edward B.; Cho, Byoung Chul; Luft, Alexander; Alatorre-Alexander, Jorge; Geater, Sarayut Lucien; Trukhin, Dmytro; Kim, Sang -We; Ursol, Grygorii; Hussein, Maen; Lim, Farah Louise; Yang, Cheng-Ta; Araujo, Luiz Henrique; Saito, Haruhiro; Reinmuth, Niels; Kohlmann, Milena; Lowery, Caitlin; Mann, Helen; Peters, Solange; Mok, Tony S.; Johnson, Melissa L. 分享 收藏
Results from phase 3 KEYLYNK-008: Pembrolizumab (pembro) with and without maintenance olaparib (ola) after first-line (1L) pembro plus chemotherapy (chemo) for metastatic squamous non-small-cell lung cancer (sqNSCLC) Hochmair, Maximilian; Schenker, Michael; Dols, Manuel Cobo; Kim, Tae Min; Kim, Sang-We; Ozyilkan, Ozgur; Smagina, Maria; Viktoriya, Leonova; Kato, Terufumi; Fedenko, Alexander; De Angelis, Flavia; Rittmeyer, Achim; Gray, Jhanelle E.; Greystoke, Alastair; Huang, Qinlei; Zhao, Bin; Lara-Guerra, Humberto; Nadal, Ernest 分享 收藏
FLAURA2: exploratory analysis of baseline (BL) and on-treatment plasma EGFRm dynamics in patients (pts) with EGFRm advanced NSCLC treated with first-line (1L) osimertinib (osi) ± platinum-pemetrexed Janne, Pasi A.; Kobayashi, Kunihiko; Robichaux, Jacqulyne; Lee, Chee Khoon; Sugawara, Shunichi; Yang, Tsung-Ying; Kim, Tae Min; Yanagitani, Noriko; Kim, Sang-We; Markovets, Aleksandra; Bhetariya, Preetida; Poole, Lynne; Ghiorghiu, Dana; Hartmaier, Ryan; Yang, James Chih-Hsin; Planchard, David 分享 收藏
分享 收藏
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial 生物标志物定向靶向治疗联合durvalumab治疗晚期非小细胞肺癌: 2期伞形试验 Besse, Benjamin; Pons-Tostivint, Elvire; Park, Keunchil; Hartl, Sylvia; Forde, Patrick M.; Hochmair, Maximilian J.; Awad, Mark M.; Thomas, Michael; Goss, Glenwood; Wheatley-Price, Paul; Shepherd, Frances A.; Florescu, Marie; Cheema, Parneet; Chu, Quincy S. C.; Kim, Sang-We; Morgensztern, Daniel; Johnson, Melissa L.; Cousin, Sophie; Kim, Dong-Wan; Moskovitz, Mor T.; Vicente, David; Aronson, Boaz; Hobson, Rosalind; Ambrose, Helen J.; Khosla, Sajan; Reddy, Avinash; Russell, Deanna L.; Keddar, Mohamed Reda; Conway, James P.; Barrett, J. Carl; Dean, Emma; Kumar, Rakesh; Dressman, Marlene; Jewsbury, Philip J.; Iyer, Sonia; Barry, Simon T.; Cosaert, Jan; Heymach, John V. 分享 收藏
Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer 罗索替尼在ROS1融合阳性非小细胞肺癌中的应用 Drilon, Alexander; Camidge, D. Ross; Lin, Jessica J.; Kim, Sang-We; Solomon, Benjamin J.; Dziadziuszko, Rafal; Besse, Benjamin; Goto, Koichi; de Langen, Adrianus Johannes; Wolf, Juergen; Lee, Ki Hyeong; Popat, Sanjay; Springfeld, Christoph; Nagasaka, Misako; Felip, Enriqueta; Yang, Nong; Velcheti, Vamsidhar; Lu, Shun; Kao, Steven; Dooms, Christophe; Krebs, Matthew G.; Yao, Wenxiu; Beg, Muhammad Shaalan; Hu, Xiufeng; Moro-Sibilot, Denis; Cheema, Parneet; Stopatschinskaja, Shanna; Mehta, Minal; Trone, Denise; Graber, Armin; Sims, Gregory; Yuan, Yong; Cho, Byoung Chul 分享 收藏
Repotrectinib in patients with ROS1 fusion-positive (ROS1+) non-small cell lung cancer (NSCLC): Update from the pivotal phase 1/2 TRIDENT-1 trial Lin, Jessica J.; Cho, Byoung Chul; Camidge, D. Ross; Kim, Sang-We; Solomon, Benjamin; Dziadziuszko, Rafal; Besse, Benjamin; Goto, Koichi; de langen, Adrianus Johannes; Wolf, Jurgen; Lee, Ki Hyeong; Popat, Sanjay; Springfeld, Christoph; Nagasaka, Misako; Felip, Enriqueta; Yang, Nong; Lu, Shun; Kao, Steven; Velcheti, Vamsidhar; Cheema, Parneet; Stopatschinskaja, Shanna; Mehta, Minal; Trone, Denise; Ades, Felipe; Calvet, Christophe Y.; Drilon, Alexander 分享 收藏
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions Zhou, Caicun; Tang, Ke-Jing; Cho, Byoung Chul; Liu, Baogang; Paz-Ares, Luis; Cheng, Susanna; Kitazono, Satoru; Thiagarajan, Muthukkumaran; Goldman, Jonathan W.; Sabari, Joshua K.; Sanborn, Rachel E.; Mansfield, Aaron S.; Hung, Jen-Yu; Boyer, Michael; Popat, Sanjay; Mourao Dias, Josiane; Felip, Enriqueta; Majem, Margarita; Gumus, Mahmut; Kim, Sang-we; Ono, Akira; Xie, John; Bhattacharya, Archan; Agrawal, Trishala; Shreeve, S. Martin; Knoblauch, Roland E.; Park, Keunchil; Girard, Nicolas; PAPILLON Investigators 分享 收藏
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC 奥希替尼联合或不联合化疗治疗EGFR突变的晚期NSCLC Planchard, D.; Janne, P. A.; Cheng, Y.; Yang, J. C. -H.; Yanagitani, N.; Kim, S-W; Sugawara, S.; Yu, Y.; Fan, Y.; Geater, S. L.; Laktionov, K.; Lee, C. K.; Valdiviezo, N.; Ahmed, S.; Maurel, J-M; Andrasina, I; Goldman, J.; Ghiorghiu, D.; Rukazenkov, Y.; Todd, A.; Kobayashi, K. 分享 收藏
First report of cohort 3 and mature survival data from the U31402-A-U102 study of HER3-DXd in EGFR-mutated NSCLC Hayashi, Hidetoshi; Yu, Helena A.; Baik, Christina; Kim, Dong-Wan; Johnson, Melissa L.; Nishio, Makoto; Yang, James Chih-Hsin; Su, Wu-Chou; Gold, Kathryn A.; Koczywas, Marianna; Smit, Egbert F.; Steuer, Conor; Felip, Enriqueta; Murakami, Haruyasu; Kim, Sang-We; Kim, Ben; Su, Xin; Tanaka, Yoshimi; Fan, Pang-Dian; Cantero, Frederique 分享 收藏
分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
CLINICAL LUNG CANCER.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏